CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it presented multiple posters and presentations at the 7th Annual Meeting of Oligonucleotide Therapeutics Society (OTS) held in Copenhagen, Denmark between September 8-10, 2011. Newly presented data include significant advances in the company’s efforts in systemic delivery of RNAi therapeutics.
